Wednesday, 14 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 30, 2026

Selling your home after 63 can be a punishing Medicare mistake. Why it could cost you thousands in added premiums

View original at finance.yahoo.com
Selling your home after 63 can be a punishing Medicare mistake. Why it could cost you thousands in added premiums For many retirees, selling their home is one of the biggest financial windfalls they’ll see outside of work — especially if they’ve owned it for decades, given the rapid rise in home prices…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • IRMAA surcharge becomes a consideration for any home sale occurring after the seller turns age 63, due to the two-year lookback period for Medicare premium determination

    80% confidence
  • IRMAA is calculated based on MAGI and generally includes capital gains, meaning the net profit from the sale of a home can push income over the IRMAA threshold

    80% confidence
  • IRS allows exclusion of up to $250,000 in capital gains for single filers and up to $500,000 for married filing jointly on primary residence sales, provided the owner lived there at least 2 of the past 5 years

    80% confidence
  • Certain home improvements, selling expenses and some closing costs can be added to your cost basis, potentially reducing taxable capital gain

    80% confidence
  • In 2026, the IRMAA threshold is $218,000 for a married couple filing jointly and $109,000 for a single individual

    80% confidence
  • The Social Security Administration generally uses income from two years prior to determine current MAGI, meaning 2026 premiums are based on 2024 income

    80% confidence
  • A typical 65-year-old is estimated to spend roughly $172,500 on total healthcare-related costs over the course of retirement

    80% confidence
  • Median home equity for homeowners age 65 and over was about $250,000 in 2022

    80% confidence
  • Monthly Medicare premiums could rise from above $202.90 to as much as $689.90 under the highest IRMAA tier

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com